Ozempic-curious people are taking a novel approach to using the blockbuster weight loss drug — and some doctors are even ...

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...

As told to Alexia Dellner Weight loss drugs like Ozempic and Wegovy have become a hot topic of late, with everyone from celebrities to your next door neighbor getting on the semaglutide train, often ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better known under the trade names Ozempic and Wegovy, is remarkable, but it's not ...

Highlights,The GLP-1 market for obesity and diabetes treatments is gaining momentum, with Novo Nordisk and Eli Lilly leading ...

Highlights,Significant Prescription Increases,: Citi reports a 244% rise in prescriptions for obesity drugs and an 18% ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Wegovy – the brand name for semaglutide, the same compound that is in Ozempic – was launched for weight loss in the US in 2021 and quickly became so popular that the manufacturer, Novo Nordisk, could ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Making correct lifestyle choices, from exercising to drinking less alcohol, can reduce risk of heart diseases and cancer ...